BVI's FINEVISION® HP Gains FDA Approval, Ushering in a New Era of Advanced Trifocal IOLs for U.S. Patients

Milestone strengthens the company’s leadership in advanced IOL innovationFINEVISION HP, with millions of implantations worldwide, will now be available to U.S. patientsProprietary design features anchor the launch of BVI’s expanded U.S. IOL portfolio WALTHAM, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BVI, a global leader in ophthalmic device innovation, today announced that the U.S. Food and Drug Administration (FDA) has approved its FINEVISION HP trifocal intraocular lens (IOL). This milestone reinforces BV ...